AstraZeneca Long Term Debt 1992-2025 | AZN
AstraZeneca long term debt from 1992 to 2025. Long term debt can be defined as the sum of all long term debt fields.
- AstraZeneca long term debt for the quarter ending June 30, 2025 was $24.714B, a 9.22% decline year-over-year.
- AstraZeneca long term debt for 2024 was $26.506B, a 18.52% increase from 2023.
- AstraZeneca long term debt for 2023 was $22.365B, a 2.61% decline from 2022.
- AstraZeneca long term debt for 2022 was $22.965B, a 18.37% decline from 2021.
| AstraZeneca Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $26,506 |
| 2023 | $22,365 |
| 2022 | $22,965 |
| 2021 | $28,134 |
| 2020 | $17,505 |
| 2019 | $15,730 |
| 2018 | $17,359 |
| 2017 | $15,560 |
| 2016 | $14,501 |
| 2015 | $14,137 |
| 2014 | $8,397 |
| 2013 | $8,588 |
| 2012 | $9,409 |
| 2011 | $7,338 |
| 2010 | $9,097 |
| 2009 | $9,137 |
| 2008 | |
